Related Experiment Video
Updated: Feb 23, 2026

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
Postchallenge hyperglycemia in subjects with low body weight: implication for small glucose volume
Takahiro Sakuma1, Koh Yamashita2, Takahiro Miyakoshi2
1Department of Medicine, Ina Central Hospital, Ina City, Nagano, Japan; sakuma@inahp.jp.
Postchallenge hyperglycemia in low body weight (BW) individuals may stem from smaller glucose volume (GV), not impaired glucose metabolism. This study suggests GV correction mitigates the apparent hyperglycemia in subjects with low BW.
Area of Science:
- Metabolic research
- Human physiology
- Endocrinology
Background:
- Postchallenge hyperglycemia is a concern in metabolic health.
- The role of glucose volume (GV) in hyperglycemia, particularly in low body weight (BW) individuals, requires further investigation.
Purpose of the Study:
- To test the hypothesis that postchallenge hyperglycemia in low BW subjects is partly due to small GV.
- To investigate the relationship between BW, glucose metabolism, and incident diabetes.
Main Methods:
- Studied 11,411 nondiabetic subjects, with a subset followed for 5.3 years.
- Assessed insulin sensitivity, secretion, and action in 1,537 subjects.
- Calculated corrected 2-hour plasma glucose (2hPGcorr) using extracellular water (ECW) as a GV surrogate.
Main Results:
- BW positively correlated with fasting plasma glucose (FPG) across its range.
- A nonlinear, J-shaped correlation was observed between BW and 2-hour plasma glucose (2hPG) and plasma glucose increment (δPG).
- In low BW subjects (≤59 kg), insulin sensitivity, secretion, and action were normal, with lower incident diabetes rates compared to heavier individuals. Corrected 2hPG (2hPGcorr) showed a linear correlation with BW, mitigating the J-shaped relationship.
Conclusions:
- Postchallenge hyperglycemia in low BW subjects is partly attributable to a smaller glucose volume (GV).
- Impaired glucose metabolism does not appear to be the primary driver of hyperglycemia in this cohort.
- GV correction provides a more accurate assessment of glucose metabolism in individuals with varying body weights.
More Related Videos
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Oral Hypoglycemic Agents: Biguanides and Glitazones